News

<>

March 17, 2017

Scrip

Is Amgen’s FOURIER Enough for Physicians, Payers to Expand Repatha Use?

By Mary Jo Laffler

Detailed results presented at ACC show a reduction in risk of major adverse cardiovascular events, but perhaps not at the level hoped for by payers.

read full article >